Letter to Dr. Woodcock by Obesity Care Continuum(OCC)

With a combined membership of over 100,000 healthcare professionals and patient advocates, the Obesity
Care Continuum is dedicated to promoting access to, and coverage of, the continuum of care surrounding the
treatment of overweight and obesity. The OCC also challenges weight bias and stigma oriented policies –
whenever and wherever they occur. The OCC is a coalition of the Obesity Action Coalition (OAC), the Obesity
Society (TOS), the American Dietetic Association (ADA), and the American Society for Metabolic and Bariatric Surgery (ASMBS).

Please read the letter in its entirety at

http://www.obesity.org/images/pdf/letter_to_fda.pdf

Another set back for Obesity fight - Amylin halts obesity drug study

It is a sad day I must say, Amylin and Takeda halted their Obesity drug study. This might be good news for Arena but certainly bad news for Obese population that are running out of options.

Article from Minyanville

FDA are you listening? Diet and Exercise are not enough to fight obesity we need more options fight this battle.